Radiomics to predict response to immunotherapy, bridging the gap from proof of concept to clinical applicability?
- PMID: 31124559
- DOI: 10.1093/annonc/mdz150
Radiomics to predict response to immunotherapy, bridging the gap from proof of concept to clinical applicability?
Comment on
-
Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers.Ann Oncol. 2019 Jun 1;30(6):998-1004. doi: 10.1093/annonc/mdz108. Ann Oncol. 2019. PMID: 30895304 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous
